Combination therapy in combating cancer.

Bayat Mokhtari, Reza; Homayouni, Tina S; Baluch, Narges; Morgatskaya, Evgeniya; Kumar, Sushil; Das, Bikul; Yeger, Herman

Bayat Mokhtari, Reza; Homayouni, Tina S; Baluch, Narges; Morgatskaya, Evgeniya; Kumar, Sushil; Das, Bikul; Yeger, Herman.

Affiliation

Bayat Mokhtari R; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Homayouni TS; Department of Paediatric Laboratory Medicine, The Hospital for Sick Children and Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Baluch N; Department of Immunology and Infectious Diseases, The Forsyth Institute, Cambridge, Massachusetts, USA.
Morgatskaya E; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Kumar S; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada.
Das B; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Yeger H; Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Oncotarget ; 8(23): 38022-38043, 2017 Jun 06.

Article de En | MEDLINE | ID: mdl-28410237

Sujet(s)
Mots clés

HIF-1alpha; Nrf2-Keap1; carbonic anhydrase 9 (CAIX); carbonic anhydrase inhibitor (CAI); histone deacetylase inhibitor (HDACi)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Inhibiteurs de l'anhydrase carbonique / Tumeurs / Antinéoplasiques Type d'étude: Systematic_reviews Limites: Humans Langue: En Journal: Oncotarget Année: 2017 Type de document: Article Pays d'affiliation: Canada Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google